Evidence map›Paper›PMID 37861791›Full record

ReviewEuropean journal of pediatrics2024

Personalized application of antimicrobial drugs in pediatric patients with augmented renal clearance: a review of literature.

Wei-Xin Xu, Qiang Qu, Xin-Qi Teng, Hai-Hui Zhuang, Si-Fan Liu, Ying Wang, Jian Qu

Abstract readReview
PubMed Publisher
In one paragraph

Review in European journal of pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Observational
  2. Observational
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Wei-Xin Xu *Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, 410011, People's Republic of China.
Qiang Qu *Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, 410078, People's Republic of China.
Xin-Qi TengDepartment of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, 410011, People's Republic of China.
Hai-Hui ZhuangDepartment of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, 410011, People's Republic of China.
Si-Fan LiuDepartment of Pharmacy, Hunan Children's Hospital, Changsha, 410007, People's Republic of China.
Ying WangDepartment of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, 410011, People's Republic of China.
Jian QuDepartment of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, 410011, People's Republic of China. qujianstanley@csu.edu.cn.
Second Xiangya Hospital of Central South University · CNCentral South University · CNChangsha Medical University · CNHunan Children's Hospital · CN

Funding

Fundamental Research Funds for Central Universities of the Central South University No. 2022XQLH154
6 · The paper itself

Abstract

The effect of renal functional status on drug metabolism is a crucial consideration for clinicians when determining the appropriate dosage of medications to administer. In critically ill patients, there is often a significant increase in renal function, which leads to enhanced drug metabolism and potentially inadequate drug exposure. This phenomenon, known as augmented renal clearance (ARC), is commonly observed in pediatric critical care settings. The findings of the current study underscore the significant impact of ARC on the pharmacokinetics and pharmacodynamics of antimicrobial drugs in critically ill pediatric patients. Moreover, the study reveals a negative correlation between increased creatinine clearance and blood concentrations of antimicrobial drugs. The article provides a comprehensive review of ARC screening in pediatric patients, including its definition, risk factors, and clinical outcomes. Furthermore, it summarizes the dosages and dosing regimens of commonly used antibacterial and antiviral drugs for pediatric patients with ARC, and recommendations are made for dose and infusion considerations and the role of therapeutic drug monitoring.

conclusionARC impacts antimicrobial drugs in pediatric patients. WHAT IS KNOWN: • ARC is inextricably linked to the failure of antimicrobial therapy, recurrence of infection, and subtherapeutic concentrations of drugs. WHAT IS NEW: • This study provides an updated overview of the influence of ARC on medication use and clinical outcomes in pediatric patients. • In this context, there are several recommendations for using antibiotics in pediatric patients with ARC: 1) increase the dose administered; 2) prolonged or continuous infusion administration; 3) use of TDM; and 4) use alternative drugs that do not undergo renal elimination.

Indexed as

Anti-Bacterial AgentsCritical IllnessChildHumansKidneyKidney Function TestsRenal EliminationAnti-Bacterial AgentsAntimicrobialsAugmented renal clearanceInfectionPediatrics

Identifiers

PMID37861791
OpenAlexW4387799129

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.